Compugen reported $22.63M in Current Liabilities for its fiscal quarter ending in June of 2026.





Current Liabilities Change Date
Arca Biopharma USD 31.78M 8.81M Sep/2026
aTyr Pharma USD 16.46M 5.07M Sep/2026
Bio Path USD 9.15M 468K Mar/2026
Brainstorm Cell Therapeutics USD 12.38M 621K Jun/2026
Cara Therapeutics USD 8.08M 3.18M Sep/2026
Clal Biotechnology ILS 6.66M 3.75M Dec/2023
Compugen USD 22.63M 596K Jun/2026
Immunic USD 31.55M 290K Sep/2026
Minerva Neurosciences USD 2.29M 381K Dec/2025
RedHill Biopharma USD 25.56M 6.34M Jun/2026
TherapeuticsMD USD 5.82M 655K Jun/2024